Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year

PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD). MATERIALS AND METHODS: Patients with treatment-naïve eAMD treated with pro re nata (PRN)...

Full description

Bibliographic Details

Main Authors:	Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani
Format:	Artigo
Language:	Inglês
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Taiwan Journal of Ophthalmology
Subjects:	age-related macular degeneration antivascular endothelial growth factor bevacizumab ziv-aflibercept
Online Access:	http://www.e-tjo.org/article.asp?issn=2211-5056;year=2020;volume=10;issue=4;spage=289;epage=293;aulast=Singh
Tags:	Add Tag No Tags, Be the first to tag this record!